Liver Transplantation for the Primary Care Provider. Atif Zaman MD MPH Oregon Health & Sciences University
|
|
- Roy Gaines
- 5 years ago
- Views:
Transcription
1 Liver Transplantation for the Primary Care Provider Atif Zaman MD MPH Oregon Health & Sciences University
2 Disclosures 1. The speaker/planner Atif Zaman, MD MPH have no relevant financial relationships to disclose. 2. The speaker/planner Lauren Myers, MMSc, PA-C have no relevant financial relationships to disclose
3 Objectives Why is LT done? How will it help my patient? Who should be referred for LT evaluation, and when? Medical considerations Psychosocial consideration What is the LT process? Referral Evaluation Transplant Post-transplant Expectations for PCPs of patients who need/get LT
4 Why is LT done? How will it help my patient? Increased survival! 5 year survival (overall) post-lt is about 80% 5 year survival for a patient with Child s Class C cirrhosis is < 20%
5 Decompensated cirrhosis is deadlier than many cancers D Amico J Hepatology 2006
6 Problems for which LT is not done Fatigue Sleeping problems Pain Elevated aminotransferases (ALT/AST)
7 LT is not as rosy as it might seem One year survival after LT (all-comers, US average) is about 90% This number has been improving over time, and 90% is considered good by those it the business It also means that there s a 10% chance an LT will kill the patient! If your chances of dying in one year are < 10%, you don t want an LT
8 How bad is cirrhosis? Will it kill me? D Amico J Hepatology 2006
9 Living with LT is better than dying but several downsides Life-long immune suppression Daily pills and frequent blood monitoring Complications of immune suppression Increased risk of cancer and rare (bad) infections Progressive renal dysfunction (and possibly failure) Cost Recurrence of original liver disease HCV infection 100% HBV infection 100% PBC/PSC 15-25% Alcohol?
10 Who should be considered for LT? Patients in whom the liver disease poses an imminent threat to life, and for whom LT could be expected to increase survival. Practically speaking: 1. Decompensated cirrhosis 2. Acute liver failure 3. Hepatocellular Carcinoma (HCC) confined to the liver
11 Reasons why patients got LT in the US in 2011 (SRTR db) Primary Cause of Disease Percentage of LT 2011 Decompensated cirrhosis 51% Acute Liver Failure 4% Liver cancer 21% Other 24%
12 MELD score MELD = Model for End-stage Liver Disease A patient s MELD score is calculated in a complex formula (available on internet, phone app) based on lab values INR Total Bilirubin Creatinine MELD range is 6 to 40 and reflects the severity of liver disease (and chance of dying)
13 MELD score and the LT list All US liver transplant centers waitlists are stratified by MELD scores Reflects a sickest first paradigm Assumes that the MELD score accurately predicts the patient s risk of dying due to liver disease
14 Reason to refer for LT consideration: Decompensated Cirrhosis This is the largest and most obvious group of patients that need LT consideration Typically have one or more symptoms/episodes Ascites Hepatic encephalopathy Variceal bleeding Fatigue
15 Reason to refer for LT consideration: Decompensated Cirrhosis This is the group for whom the MELD score makes the most sense Timing to refer the patient for LT consideration can best be achieved by paying attention to the MELD score Rule of thumb: when a patient s MELD reaches about 15, this is a good time to refer for LT evaluation MELD scores at the top of our list is are the mid-20s A MELD of 15 would put a patient about 40 th on our transplant list (so this is in plenty of time)
16 Patient with decompensated cirrhosis is sicker than MELD indicates The MELD score is not perfect! (It s ~ 85% predictive) If a patient seems very sick but the MELD score is not that high (say <15), this is a good time to run the case by a transplant hepatologist May simply need specialty help in treating complications May reflect a special consideration for LT despite low MELD May reflect non-liver disease that is causing clinical troubles LT not helpful if the liver is not the problem!
17 Reason to refer for LT consideration: Acute Liver Failure Rare (~2000 cases per year in the US) Deadly (very high mortality in absence of LT) Need specialty care immediately MELD score not used on LT list for this group
18 Acute Liver Failure (ALF) Coagulopathy (INR > 1.5) Encephalopathy No prior liver disease ( acute ) Noted abnormalities are due to the liver Liver function failing (coagulopathy + encephalopathy) Not elevated AST/ALT
19 Acute Liver Failure (ALF) Coagulopathy (INR > 1.5) Encephalopathy No prior liver disease ( acute ) Noted abnormalities are due to the liver Liver function failing (coagulopathy + encephalopathy) Not elevated AST/ALT Contact a transplant hepatologist immediately
20 Hepatocellular Carcinoma (HCC) Screening for HCC All patients with cirrhosis Selected patients with chronic HBV infection
21 Liver Transplantation for HCC Why transplant for HCC? 1. HCC is deadly (very) 2. HCC is usually (~90% of the time) non-resectable (not curable) 3. In selected patients, LT cures HCC (as well as the usuallycirrhotic liver)
22 Liver Transplantation for HCC Patients with HCC usually have cirrhosis, but often the cirrhosis is not advanced HCC patients often have low MELD scores If HCC patients were listed by their biological MELD score, they would be near the bottom of lists, and likely die from HCC progression before LT
23 Liver Transplantation for HCC Patients on the LT list who have HCC are thus given a MELD exception of 22 once they have been listed for 6 months MELD Increases if not transplanted within 3 months This allocation strategy is favoring patients with HCC over patients with decompensated cirrhosis May change, but who knows when?
24 Management of HCC Very complicated, really must have multi-disciplinary team (ideally one that includes LT as an option) PCP role: understand indications for screening for HCC, be diligent about screening Seek feedback from go-to Multi-D HCC group if HCC is detected on screening
25 Exceptions to MELD-based stratification on LT list The way it works: Any LT center can list any patient at any time Stratification on the list, however, is by MELD score (law) If a center wants a particular patient higher on the list than the patient s MELD indicates, an exception can be requested This request goes to other LT centers in the region for a vote, and if the vote is aye then the patient gets the requested MELD score
26 Typical successful requests for MELD exceptions HCC (most common by far) Primary Biliary Cirrhosis: itching Primary Sclerosing Cholangitis: recurrent cholangitis Hepatopulmonary Syndrome: pao 2 < 60 mmhg
27 Summary: medical reasons to request LT evaluation Decompensated cirrhosis, MELD > 15 Acute liver failure HCC
28 Other parts of the LT package: what you patient does and doesn t need Overall medical condition (outside of the liver) Substance abuse issues Social support and compliance Financial capability
29 Medical condition outside the liver In general, as the number of medical co-morbidities increase, the chances of having a successful outcome peri/post-lt decrease Really big problems: Significant cardiac or pulmonary disease Diabetes mellitus Renal failure
30 Nutrition and state of conditioning Patients with poor nutrition and physically debilitated do poorly after LT
31 Substance abuse and LT Huge problem In general, LT programs do not transplant patients with active or recently active substance abuse problems
32 Typical requirement for LT listing around the country 6 months abstinence from alcohol and drugs
33 Portland VA and OHSU requirements (also fairly typical) If patient has a drug/alcohol problem: Six months abstinence minimum Successful completion of substance abuse rehabilitation program Ongoing recovery support No tobacco use at all If using, cessation followed by 4 consecutive weekly neg screens
34 LT psychosocial considerations LT programs want to determine whether the patient and his/her environment will support LT All comes down to ability to comply with post-lt regimen Without this compliance, allografts (and patients) don t make it!
35 What psychosocial considerations affect pre- and post-lt compliance? Drug and alcohol problems Significant psychiatric disease Including personality disorders Inadequate social support Inadequate financial resources/stability
36 What psychosocial considerations affect pre- and post-lt compliance? Drug and alcohol problems Significant psychiatric disease Including personality disorders Inadequate social support Inadequate financial resources/stability Psychosocial difficulties are the main reasons why patients are denied listing for LT
37 The process: LT referral Can be initiated by PCP or specialist Goes through initial medical and administrative review If no red flags, evaluation is scheduled and prioritized depending on medical urgency
38 The process: LT referral Can be initiated by PCP or specialist Goes through initial medical and administrative review If no red flags, evaluation is scheduled and prioritized depending on medical urgency This does not mean the patient is on the list!
39 The process: LT evaluation Usually takes several days to a week (if outpatient) The patient typically sees Transplant surgeon Transplant hepatologist Social worker Psychologist/psychiatrist Dietician Transplant coordinator nurse May see a chaplain May see an addictions specialist
40 The process: LT evaluation Medical work-up includes Blood work (lots of it) Assessment for CAD (some kind of stress test) Assessment of pulmonary function (PFTs, ABG) Contrast scan of the abdomen Looking for HCC as well as assessment of hepatic vasculature Other things that may have been identified during the referral Consult with ID (if positive PPD or other reason) Consult with Cardiology (if prior heard problem identified)
41 LT evaluation: inpatient or outpatient? Inpatient is for patients who are hospitalized, very ill and not expected to leave the hospital without LT Inpatient evaluations are difficult on everyone (especially the patient) and should be avoided if possible Chances of getting listed are lower Evaluation may reveal some aspect that needs work before listing, and there may not be sufficient time in the hospitalized patient
42 The process: LT evaluation After evaluation meetings and testing, the patient is presented at a weekly Transplant Selection Conference Three outcomes from Transplant Selection Conference 1. Accept (the patient will be put on the list) 2. Decline (the patient will not be put on the list) 3. Defer (the patient will be put on the list after doing X,Y &Z)
43 Details for deferment Easy things to do Get a vaccination Get a neurology (derm, renal, etc) consult Get a colonoscopy See the dentist Hard things to do Successfully complete a drug/alcohol rehab, develop ongoing recovery support Get an adequate social support person (or backup) Get adequate insurance Stop smoking
44 Details often needing completing before listing not done at LT center EGD and colonoscopy (if not already done) Vaccinations PPD Dental clearance Drug/alcohol rehab (can be done through VA)
45 Details often needing completing before listing not done at LT center EGD and colonoscopy (if not already done) Vaccinations PPD Dental clearance Drug/alcohol rehab (can be done through VA) Usually the job of the referring physician to assist the patient in such requirements
46 The process: patient listed for LT Patient is on the LT list corresponding to blood type Thus, 4 lists (O, A, B, AB) Stratified according to MELD score Either biological or exception (HCC or other) Where am I on the list? A frequent question by patients and providers, and very difficult to answer (because list changes daily due to new patients and changing illness severity of listed patients) 1. At the top 2. In the top five 3. In the top half 4. In the bottom half
47 The process: patient listed for LT Patient must have MELD re-verified periodically Labs every 3 months minimum Cardiac status must be re-verified periodically Echo, maybe stress test yearly if near top of list Patient must be seen by team (hepatologist) periodically Frequency depends on illness of patient Patient must have imaging periodically Usually every 6 months, US/CT/MRI or some alternating combo
48 The process: transplant The Organ Procurement Organization (OPO) calls the transplant surgeon: We have a liver for Mr. X Prior to this call, the donor patient has been determined to be brain dead or no chance of survival Donor consent (often through family) obtained Risk factors for prior liver disease assessed Blood testing for liver function done Testing for HIV, Hepatitis B and C done
49 The process: transplant Surgeon, hepatologist, or nurse coordinator calls patient Are you okay? No new complications that might preclude transplant Do you want this liver? Risk factors for the donor liver discussed briefly Any physical obstacles to coming to LT center immediately?
50 The process: transplant After agreement that the patient wants the liver, s/he starts for the hospital immediately Transplant team goes to hospital to harvest donor organ Patient admitted to the hospital Brief clinical assessment, labs, sometimes a scan Donor organ arrives at hospital, patient taken to OR, liver transplant done 4 to 12 hours
51 Post-LT to hospital discharge Takes usually 1-2 weeks in the hospital Infrequently serious complications arise, and patients can be hospitalized for months, or die in this period After hospital discharge, patients are seen 1-2 times weekly in the transplant clinic Cannot leave the city Seeing transplant surgeons in the clinic After 1-2 months, can leave city At 3 months, switched from seeing surgeons back to the hepatologists (indefinitely)
52 Post-LT three to six months Still on prophylactic medications due to the profound immune suppression PCP prophylaxis for 6 months (Septra, Bactrim, Pentamidine) CMV prophylaxis (Valgancyclovir) Fungal prophylaxis (Fluconazole) Immune suppression Usually off prophylactic medications by 6 months, and on stable immune suppression
53 Post-LT: immune suppression Backbone Tacrolimus Cyclosporin Sirolimus Anti-metabolite Azathioprine Mycophenolate Corticosteroids Prednisone
54 Expectations for the PCP: pre-lt Recognize when the patient needs to be evaluated for LT Work with LT center on items to complete so that the patient can be listed for LT Help the LT center to get tests as the need arises in order to keep the patient on the list Consult the LT center when something (medically or psychosocially) changes in the patient s status
55 Expectations for the PCP: post-lt Facilitate recurring labs for the post-lt patient Always emphasize that labs should be drawn an hour or less prior to when the patient takes his/her immunosuppressives! Help the patient with routine medical problems that may be brought on/exacerbated by LT Diabetes mellitus (very common) HTN Osteoporosis Yearly skin exams
Evaluation Process for Liver Transplant Candidates
Evaluation Process for Liver Transplant Candidates 2 Objectives Identify components of the liver transplant referral to evaluation Describe the role of the liver transplant coordinator Describe selection
More informationEvaluating HIV Patient for Liver Transplantation. Marion G. Peters, MD Professor of Medicine University of California San Francisco USA
Evaluating HIV Patient for Liver Transplantation Marion G. Peters, MD Professor of Medicine University of California San Francisco USA Slide 2 ESLD and HIV Liver disease has become a major cause of death
More informationEvaluation Process for Liver Transplant Candidates
Evaluation Process for Liver Transplant Candidates 2 Objectives Identify components of the liver transplant referral to evaluation Describe the role of the liver transplant coordinator Describe selection
More informationLiver Transplantation Evaluation: Objectives
Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation
More informationLiver Transplantation
Liver Transplantation Dr Mathew Jacob - MRCS FRCS CCT (UK) Lead Consultant HPB/Transplant Surgeon Aster Integrated Liver Care Program AsterMedcity, kochi, kerala, India mathew@transplantationliver.com
More informationInformed Consent for Liver Transplant Patients
Informed Consent for Liver Transplant Patients Evaluation Process You will be evaluated with consultations, lab tests and various procedures to determine the medical appropriateness of liver transplant.
More informationYour Health Matters. What You Need to Know about Adult Liver Transplantation. Access our patient education library online at
Access our patient education library online at www.ucsfhealth.org Your Health Matters What You Need to Know about Adult Liver Transplantation Table of Contents 1. Introduction 2. The Preliminary Process
More informationTransplant Hepatology
Transplant Hepatology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified
More informationASSESSMENT AND MANAGEMENT OF POTENTIAL LIVER TRANSPLANT CANDIDATES
ASSESSMENT AND MANAGEMENT OF POTENTIAL LIVER TRANSPLANT CANDIDATES James YY Fung MBChB, MD, FRACP, FHKCP, FHKAM Consultant & Hon. Assoc. Professor Liver Transplant Center Department of Surgery, Queen Mary
More informationObjectives 2/11/2016 HOSPICE 101
HOSPICE 101 Overview Hospice History and Statistics What is Hospice? Who qualifies for services? Levels of Service The Admission Process Why Not to Wait Objectives Understand how to determine hospice eligibility
More informationIowa Methodist Medical Center Transplant Center. Informed Consent for Kidney Transplant Recipient
Iowa Methodist Transplant Center Iowa Methodist Medical Center Transplant Center 1215 Pleasant Street, Suite 506 Des Moines, IA 50309 515-241-4044 Phone 515-241-4100 Fax Iowa Methodist Medical Center Transplant
More informationAlcoholism and Alcohol Liver Disease from a Transplant Hepatology Perspective
Alcoholism and Alcohol Liver Disease from a Transplant Hepatology Perspective Clark Kulig, MD Director, Porter Center for Liver Care Denver, CO February 2015 Does quantity of alcohol correlate with liver
More informationHepatology For The Nonhepatologist
Hepatology For The Nonhepatologist Andrew Aronsohn, MD Associate Professor of Medicine University of Chicago Chicago, Illinois Learning Objectives After attending this presentation, learners will be able
More informationWHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT
WHEN HCV TREATMENT IS DEFERRED WV HEPC ECHO PROJECT October 13, 2016 Reminder - treatment is recommended for all patients with chronic HCV infection Except short life expectancies that cannot be remediated
More informationHepatitis C Virus (HCV): Current Screening Guidelines and Treatment Approaches
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/hepatitis-c-virus-hcvcurrent-screening-guidelines-treatment-approaches/9514/
More informationOntario s Adult Referral and Listing Criteria for Liver Transplantation
Ontario s Adult Referral and Listing Criteria for Liver Transplantation Version 3.0 Trillium Gift of Life Network Ontario s Adult Referral & Listing Criteria for Liver Transplantation PATIENT REFERRAL
More informationLiver Transplantation By: Kay R. Brown, CLCP
Liver Transplantation By: Kay R. Brown, CLCP Dr. Jeffrey Crippin, Director of Hepatology at the Baylor Institute of Transplantation in Dallas, Texas outlined during the Transplantation '97 seminar the
More informationThe Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist. K V Speeg, MD, PhD UT Health San Antonio
The Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist K V Speeg, MD, PhD UT Health San Antonio Objectives Review staging of liver disease Review consequences of end-stage
More informationInformation for patients (and their families) waiting for liver transplantation
Information for patients (and their families) waiting for liver transplantation Waiting list? What is liver transplant? Postoperative conditions? Ver.: 5/2017 1 What is a liver transplant? Liver transplantation
More informationInova Transplant Center
Inova Transplant Center I think I am a great candidate! Out with the old! in with the new! Help us help you! Pretransplant evaluation: goals Determine suitability as candidate Nature of surgery Optimize
More informationSo let s go through each disease then and understand some of the established prognostic factors starting with COPD.
Okay, I am Dr. David Hui from the Department of Palliative Care from The University of Texas MD Anderson Cancer Center and we are going to talk about Prognostication in Advanced Diseases, Part II. So in
More informationOrgan Allocation in Pennsylvania: Current concepts and future directions
Organ Allocation in Pennsylvania: Current concepts and future directions David Goldberg, MD, MSCE Assistant Professor of Medicine and Epidemiology Medical Director of Living Donor Liver Transplantation
More informationLearning Objectives. After attending this presentation, participants will be able to:
Learning Objectives After attending this presentation, participants will be able to: Describe HCV in 2015 Describe how to diagnose advanced liver disease and cirrhosis Identify the clinical presentation
More informationMedical Writers Circle October 2008
The HCV Advocate www.hcvadvocate.org Medical Writers Circle October 2008 a series of articles written by medical professionals about the management and treatment of hepatitis C Lorenzo Rossaro, M.D., F.A.C.P.,
More information4/26/2017. Liver Transplant and Palliative Care: Teaming up to improve care
Liver Transplant and Palliative Care: Teaming up to improve care Jody C. Olson, M.D., FACP Assistant Professor of Medicine and Surgery Hepatology and Critical Care Medicine All patients with end-stage
More informationPatient Education. Transplant Services. For a liver transplant
Patient Education Preparing for Medical Evaluation, Labs & Tests For a liver transplant The evaluation process is complex and is unique to each patient. The Transplant Team will determine whether the real
More informationAbnormal Liver Chemistries. Lauren Myers, MMsc. PA-C Oregon Health and Science University
Abnormal Liver Chemistries Lauren Myers, MMsc. PA-C Oregon Health and Science University Disclosure 1. The speaker/planner Lauren Myers, MMSc, PA-C have no relevant financial relationships to disclose
More informationOverall Goals and Objectives for Transplant Hepatology EPAs:
Overall Goals and Objectives for Transplant Hepatology EPAs: 1. DIAGNOSTIC LIST During the one-year Advanced Pediatric Transplant Hepatology Program, fellows are expected to develop comprehensive skills
More informationRoad Blocks in Non-Cancer Palliative Care Obstacles observed from outpatient non-cancer palliative practice.
Road Blocks in Non-Cancer Palliative Care Obstacles observed from outpatient non-cancer palliative practice. 25th Annual Palliative Education and Research Days, West Edmonton Mall. Edmonton. 2014 Amanda
More informationHepatitis C: How sick can we treat? Robert S. Brown, Jr., MD, MPH Vice Chair, Transitions of Care Interim Chief, Division of
Hepatitis C: How sick can we treat? Robert S. Brown, Jr., MD, MPH Vice Chair, Transitions of Care Interim Chief, Division of Gastroenterology & Hepatology www.livermd.org HCV in advanced disease In principle
More informationHigh-Impact HIV Prevention: A Step-By-Step Implementation Approach
Capacity Building Assistance for High Impact HIV Prevention: Session 3 High-Impact HIV Prevention: A Step-By-Step Implementation Approach Hildi Hagedorn, PhD Center for Chronic Disease Outcomes Research
More informationEVALUATION & LISTING. Your Child s Liver Transplant Evaluation. What is the Liver?
EVALUATION & LISTING Your Child s Liver Transplant Evaluation The University of Michigan is a national leader in liver transplantation, as well as the surgical and medical management of patients with liver
More informationEnd Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC
End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP-BC Introduction (https://www.srtr.org) What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC
More informationEnd Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC
End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC Introduction (https://www.srtr.org) 1 What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC
More informationEntrustable Professional Activity
Entrustable Professional Activity 1. EPA Title: Care of infants, children and adolescents with acute and chronic s 2. Description of Activity Practicing subspecialists must be trained to care for children
More informationAscites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology
Ascites Management Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Disclosure 1. The speaker Atif Zaman, MD MPH have no relevant
More informationPatients must have met all of the following inclusion criteria to be eligible for participation in this study.
Supplementary Appendix S1: Detailed inclusion/exclusion criteria Patients must have met all of the following inclusion criteria to be eligible for participation in this study. Inclusion Criteria 1) Willing
More informationCauses of Liver Disease in US
Learning Objectives Updates in Outpatient Cirrhosis Management Jennifer Guy, MD MAS Director, Liver Cancer Program California Pacific Medical Center guyj@sutterhealth.org Review cirrhosis epidemiology,
More informationThanks to our Speakers!
Thanks to our Speakers! Fizza Naqvi, MD Assistant Professor at the Department of Medicine (Nephrology), Johns Hopkins Attending physician at Johns Hopkins hospital. Involved with kidney recipient evaluation
More informationWhat Every Non-hepatologist Should Know About Caring For Transplanted Patients. Gia Tyson, MD, MPH Ochsner Health System March 31, 2017
What Every Non-hepatologist Should Know About Caring For Transplanted Patients Gia Tyson, MD, MPH Ochsner Health System March 31, 2017 Agenda Liver transplant statistics Post-transplant patient information
More informationOntario s Referral and Listing Criteria for Adult Heart Transplantation
Ontario s Referral and Listing Criteria for Adult Heart Transplantation Version 3.0 Trillium Gift of Life Network Adult Heart Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The
More informationJohns Hopkins Hospital Comprehensive Transplant Center Informed Consent Form for Thoracic Organ Recipient Evaluation
Johns Hopkins Hospital Comprehensive Transplant Center Informed Consent Form for Thoracic Organ Recipient Evaluation The decision to undergo transplantation can be extremely difficult and often confusing.
More informationHepatocytes produce. Proteins Clotting factors Hormones. Bile Flow
R.J.Bailey MD Hepatocytes produce Proteins Clotting factors Hormones Bile Flow Trouble.. for the liver! Trouble for the Liver Liver Gall Bladder Common Alcohol Hep C Fatty Liver Cancer Drugs Viruses Uncommon
More informationStep One: The Referral
Step One: The Referral There are 3 phases of your journey through kidney transplant. They are: 1. Referral and Evaluation 2. Wait List 3. Post-Kidney Transplant In this section, you will find information
More informationBut. therefore, I: Liver Transplantation a non transplant centre perspective HOW AM I QUALIFIED TO DO THIS?
Liver Transplantation a non transplant centre perspective Dermot Gleeson Consultant Hepatologist Gastroententerology SpR 29th September 2012 Clinical Update HOW AM I QUALIFIED TO DO THIS? Don t work in
More informationLiver Transplantation: The End of the Road in Chronic Hepatitis C Infection
University of Massachusetts Medical School escholarship@umms UMass Center for Clinical and Translational Science Research Retreat 2012 UMass Center for Clinical and Translational Science Research Retreat
More informationHeart Transplant Family Education Class
Heart Transplant Family Education Class Celebrating 30 years History of Heart Transplantation First successful adult heart transplant in United States- January 6, 1968 First heart transplant at OHSU -
More informationLiver disease in 2017: challenges and opportunities
Liver disease in 2017: challenges and opportunities Dr Matthew Cowan Consultant Gastroenterologist and Hepatologist Surrey and Sussex Healthcare NHS Trust Faculty of Physician Associates 2 nd National
More informationChapter 4 Section 24.1
Surgery Chapter 4 Section 24.1 Issue Date: October 27, 1995 Authority: 32 CFR 199.4(e)(5) 1.0 CPT 1 PROCEDURE CODES 32850-32854, 33930-33935 2.0 DIAGNOSTIC RELATED GROUPS (DRGs) 495 for lung transplant.
More informationLung Transplantation for Cystic Fibrosis
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/cystic-fibrosis-in-focus/lung-transplantation-cystic-fibrosis/8306/
More informationIntentional Transplantation of Hepatitis C Positive Livers into Hepatitis C Negative Recipients- Report of the first Case Series in World
Intentional Transplantation of Hepatitis C Positive Livers into Hepatitis C Negative Recipients- Report of the first Case Series in World Paulo Martins MD PhD, Aaron Ahearn MD PhD, Babak Movahedi MD PhD,
More informationPart I. Prior Authorization Criteria and Policy
Texas Vendor Drug Program Antiviral Agents for Hepatitis C Virus Initial Authorization Request (Medicaid) Part I. Prior Authorization Criteria and Policy March 2018-E I. Eligibility 1. Patient is enrolled
More informationDictionary of Organ Donation and Transplantation Terms
Dictionary of Organ Donation and Transplantation Terms Acute Rejection: The body s attempt to destroy the transplanted organ. Acute rejection usually occurs in the first year after transplant. Adverse
More informationChronic liver failure Assessment for liver transplantation
Chronic liver failure Assessment for liver transplantation Liver Transplantation Dealing with the organ shortage Timing of listing must reflect length on waiting list Ethical issues Justice, equity, utility
More information7.Integrating quit lines into health systems
7.Integrating quit lines into health systems Why should quit-line planners, promoters and service providers consider how their quit line could be integrated into health-care delivery systems in their country?
More informationLong term liver transplant management
Long term liver transplant management Dr Bill Griffiths Cambridge Liver Unit Royal College of Physicians 5.7.17 Success of Liver Transplantation Current survival, 1 st elective transplant: 1 yr survival
More informationInitial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH
Initial Evaluation for HCV Therapy Hope McGratty PA-C, MPH Conflict of Interest Disclosure Statement None Who are we talking about today? Treatment naïve Chronic infection This patient seems complicated
More informationHepatitis C Virus (HCV)
Clinical Practice Guidelines Hepatitis C Virus (HCV) OBJECTIVE The purpose is to guide the appropriate diagnosis and management of Hepatitis C Virus (HCV). GUIDELINE These are only guidelines, and are
More informationDr. John C Rwegasha.FRCP(Lond),MSc, Muhimbili National Hospital Dar es Salaam Tanzania 15/09/2018 1
Dr. John C Rwegasha.FRCP(Lond),MSc, Muhimbili National Hospital Dar es Salaam Tanzania 15/09/2018 1 No disclosures. 15/09/2018 2 Sub-Saharan Africa (SSA) has a high burden of morbidity and mortality resulting
More informationAlcoholic Hepatitis: Routine Screening for Early Recognition and Management. Juan Guerrero, MD
Alcoholic Hepatitis: Routine Screening for Early Recognition and Management Juan Guerrero, MD Global Problem 1% of GNP of medium/high income countries Additional societal costs Disproportionately affects
More informationTransplantUpdate. A Report From Baylor Regional Transplant Institute Volume 1 Number 4
TransplantUpdate A Report From Baylor Regional Transplant Institute Volume 1 Number 4 Alcoholic Liver Disease 2 Alcoholic liver disease is the second leading indication for liver transplantation in the
More informationCHAPTER 3 SECTION 1.6B HEART-LUNG AND LUNG TRANSPLANTATION TRICARE POLICY MANUAL M, MARCH 15, 2002 SURGERY AND RELATED SERVICES
TRICARE POLICY MANUAL 6010.47-M, MARCH 15, 2002 SURGERY AND RELATED SERVICES CHAPTER 3 SECTION 1.6B ISSUE DATE: October 27, 1995 AUTHORITY: 32 CFR 199.4(e)(5) I. CODES A. CPT 1 Procedure Codes 33930, 33935,
More informationSeptember 28, 2013 Jennifer Butler, RN, CCTC
How To Get Listed for Kidney Transplant September 28, 2013 Jennifer Butler, RN, CCTC Objectives What kidney failure is 3 major forms of treatment Kidney transplant evaluation Kidney transplant List Functions
More informationLive Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease
Live Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease Abhi Humar, MD Clinical Director, Thomas E. Starzl Transplantation Institute 1 PITTSBURGH THE BIRTHPLACE OF LIVER TRANSPLANTATION
More informationCommunity and Mental Health Services. Palliative Care. Criteria and
Community and Mental Health Services Specialist Palliative Care Service Referral Criteria and Guidance November 2018 Specialist Palliative Care Service Referrals These guidelines cover referrals for patients
More informationChapter 4 Section Combined Heart-Kidney Transplantation (CHKT)
Surgery Chapter 4 Section 24.3 Issue Date: May 7, 1999 Authority: 32 CFR 199.4(e)(5) 1.0 POLICY 1.1 is a TRICARE benefit that requires preauthorization. 1.1.1 A TRICARE Prime enrollee must have a referral
More informationOne of the areas where it's certainly made it difference is with the transplantation of the liver. Dr. Roberts thinks so much for joining us.
Benefits and Risks of Living Donor Liver Transplant Webcast May 28, 2008 John Roberts, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center,
More informationHepatitis C Policy Discussion
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationManagement of the Patient with Chronic Hepatitis C LAUREN MYERS MMSC, PA-C OREGON HEALTH & SCIENCE UNIVERSITY
Management of the Patient with Chronic Hepatitis C LAUREN MYERS MMSC, PA-C OREGON HEALTH & SCIENCE UNIVERSITY Disclosures Nothing to disclose Management of the Patient with Chronic Hepatitis C Communicate
More informationManagement of Alcoholic Liver Disease. Hafez Fakheri Professor of medicine, Sari, Iran
Management of Alcoholic Liver Disease Hafez Fakheri Professor of medicine, Sari, Iran Alcoholic Hepatitis Scores DF = (4.6 x [ PT- control PT]) + (bili ) MELD = 10 * ((0.957 * ln(cr)) + (0.378 * ln(bil))
More informationPrimary Care Approach to Diagnosis and Management of Chronic Hepatitis C Brian Viviano, D.O.
Primary Care Approach to Diagnosis and Management of Chronic Hepatitis C Brian Viviano, D.O. Objectives Epidemiology of chronic hepatitis C CDC guidelines on screening or hepatitis C Diagnosing hepatitis
More informationa series of fact sheets written by experts in the field of liver disease HCV DISEASE PROGRESSION
www.hcvadvocate.org HCSP FACT SHEET Foreword Over years or decades, chronic hepatitis C virus (HCV) infection can progress to severe liver problems including cirrhosis and hepatocellular carcinoma (HCC).
More informationPresentation. SG is a 57 yo white man diagnosed with HCV 10 years ago now contemplating retreatment PMHx:
A HCV Dilemma Presentation SG is a 57 yo white man diagnosed with HCV 10 years ago now contemplating retreatment PMHx: Psoriasis Mild depression 5 years prior treated with PEG/RBV for 12 months HCV PCR
More informationHepatitis C Information Sheet.
Department of Gastroenterology 4225 Hoyt Avenue, Suite A Everett, Washington 98203-2318 (425) 259-3122 * (425) 252-9860 fax Hepatitis C Information Sheet. What you should know about having HCV infection:
More informationWhat is a Trauma Center? What is a Trauma Center? Minnesota Trauma Centers. Alcohol Screening and Brief Intervention in the Trauma Center Setting
What is a Trauma Center? Alcohol Screening and Brief Intervention in the Trauma Center Setting Alison Pence, MPH North Memorial Medical Center Robbinsdale,, MN Trauma Center is a designation given by the
More informationMonitoring Patients Who Are Starting HCV Treatment, Are On Treatment, Or Have Completed Therapy
Monitoring Patients Who Are Starting HCV Treatment, Are On Treatment, Or Have Completed Therapy WV ECHO August 10, 2017 Selection of patients for HCV treatment Despite current guidance to treat everyone,
More informationOrgan Transplants for Cancer Treatment
Organ Transplants for Cancer Treatment Guest Expert: Sukru, MD Director, Yale-New Haven Hospital Transplant Service www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with doctors
More informationHepatitis C Medications Hawaii PRIOR AUTHORIZATION REQUEST FORM
Please complete this entire form and fax it to: 866-940-7328. If you have questions, please call 800-310-6826. This form contains multiple pages. Please complete all pages to avoid a delay in our decision.
More informationNational liver offering scheme
1 National liver offering scheme Outline 1 Hub Specialist Nurse Organ Donation (SNOD) registers donor with Operations 2 matching Hub Operations initiates the run 3 Hub Matching run offering list printed
More informationClinic Procedures. After your heart transplant. Lab Tests
UW MEDICINE PATIENT EDUCATION Clinic Procedures After your heart transplant We hope your new heart puts you on the road to a productive, healthy, and happy life. To be sure you and your heart are doing
More informationLIVER TRANSPLANTATION
Program and Surgical Director: Charles Miller, MD Medical Director: Nizar N. Zein, MD 216.444.8770 clevelandclinic.org/livertx Liver LIVER TRANSPLANTATION Cleveland Clinic performed 128 liver transplants
More informationThe New World of HCV Therapy
HCV: Assessing the Patient Prior to Treatment: Diagnostic Testing and Strategy JORGE L. HERRERA M.D., MACG UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE, MOBILE, AL The New World of HCV Therapy Interferon-free
More informationUPMC Thomas E. Starzl Transplantation Institute Innovative and Novel Indications for Live Donor Liver Transplant (LDLT)
UPMC PRESBYTERIAN SHADYSIDE TRANSPLANT POLICIES AND PROCEDURES UPMC Thomas E. Starzl Transplantation Institute Innovative and Novel Indications for Live Donor Liver Transplant (LDLT) Alcoholic hepatitis
More informationThe New World of HCV Therapy
HCV: Assessing the Patient Prior to Treatment: Diagnostic Testing and Strategy JORGE L. HERRERA, MD, MACG UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE, MOBILE, AL The New World of HCV Therapy Interferon-free
More informationAssessing the patient with a new diagnosis of Hepatitis C LAUREN MYERS MMSC, PA-C OREGON HEALTH & SCIENCE UNIVERSITY
Assessing the patient with a new diagnosis of Hepatitis C LAUREN MYERS MMSC, PA-C OREGON HEALTH & SCIENCE UNIVERSITY Disclosures Nothing to Disclose Assessing the patient with a new diagnosis of Hepatitis
More informationTA L K I N G A B O U T T R A N S P L A N TAT I O N
TA L K I N G A B O U T T R A N S P L A N TAT I O N Frequently Asked Questions about Kidney Transplant Evaluation and Listing If your kidneys have stopped working properly, or may stop working soon, you
More informationLiver Disease. By: Michael Martins
Liver Disease By: Michael Martins Recently I have been getting a flurry of patients that have some serious liver complications. This week s literature review will be the dental management of the patients
More informationSpecialist Palliative Care Service Referral Criteria and Guidance
Specialist Palliative Care Service Referral Criteria and Guidance Specialist Palliative Care Service Referrals These guidelines cover referrals for patients with progressive terminal illness, whether
More informationEsophageal Cancer. Source: National Cancer Institute
Esophageal Cancer Esophageal cancer forms in the tissues that line the esophagus, or the long, hollow tube that connects the mouth and stomach. Food and drink pass through the esophagus to be digested.
More informationDISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea
DISCLOSURES This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea Cardea Services is approved as a provider of continuing nursing education by Montana Nurses Association,
More informationInvestigations before OLT, Immunosuppression and rejection, Follow up after OLT.
Investigations before OLT, Immunosuppression and rejection, Follow up after OLT andrea.degottardi@insel.ch When is liver transplantation indicated? When is liver transplantation indicated? Frequent: CIRRHOSIS
More informationMANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT
MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT Sherona Bau, ACNP The Pfleger Liver Institute 200 UCLA Medical Plaza, Suite 214 Los Angeles, CA 90095 September 30, 2017 I
More informationMolina Healthcare of Texas Hepatitis C Drugs (Medicaid)
Texas Standard Prior Authorization Form Addendum Molina Healthcare of Texas Hepatitis C Drugs (Medicaid) This fax machine is located in a secure location as required by HIPAA Regulations. Complete / Review
More informationAlpha-1 Antitrypsin Deficiency: Liver Disease
Alpha-1 Antitrypsin Deficiency: Liver Disease Who is at risk to develop Alpha-1 liver disease? Alpha-1 liver disease may affect children and adults who have abnormal Alpha-1 antitrypsin genes. Keys to
More informationGeorgia Regents. Kidney and Pancreas Transplant Program. Welcome!
Georgia Regents. Kidney and Pancreas Transplant Program Welcome! Orientation Packet Your packet includes forms for you to review. The forms will be explained again during your work up. Patient Education
More informationSteps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV
Overview of Liver Disease Associated With HCV Marion G. Peters, MD John V. Carbone, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco San Francisco,
More informationLIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.
LIVER CIRRHOSIS William Sanchez, M.D. & Jayant A. Talwalkar, M.D., M.P.H. Advanced Liver Disease Study Group Miles and Shirley Fiterman Center for Digestive Diseases Mayo College of Medicine Rochester,
More information